Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

FedEx Q3 Profit Rises; Updates 2012 EPS View - Quick Facts

RELATED NEWS
Trade FDX now with 

FedEx Corp. (FDX: Quote) posted third-quarter net income of $521 million or $1.65 per share, up from $231 million or $0.73 per share a year ago.

Earnings for the recent quarter includes a $0.10 per share reversal of a reserve associated with a legal matter at FedEx Express. Last year's third quarter earnings included $0.08 per share in costs related to the combination of the company's FedEx Freight and FedEx National LTL operations.

Adjusted earnings per share were $1.55 versus $0.81 in the same quarter last year. On average, 23 analysts polled by Thomson Reuters expected the company to report earnings of $1.35 per share. Analysts' estimates typically exclude special items.

Revenue reached $10.56 billion, up 9% from $9.66 billion in the previous year Analysts estimated revenues of $10.62 billion.

"FedEx Corp. results were driven by improving yields, record holiday package shipping and exceptional performance at FedEx Ground," said Frederick Smith, FedEx Corp. chairman, president and chief executive officer. "We expect our solid performance to continue in our fourth quarter, capping off a strong fiscal year."

Looking ahead, FedEx projects earnings to be $1.75 to $2.00 per share in the fourth quarter. Analysts expect the company to earn $1.98 per share for the quarter.

The company now expects an adjusted earnings of $6.35 to $6.60 per share for fiscal 2012. This guidance assumes the current market outlook for fuel prices and moderate growth in the global economy. Including the FedEx Express legal reserve reversal, earnings are now expected to be $6.43 to $6.68 per share for fiscal 2012.

Earlier, the company expected earnings of $6.25 to $6.75 per share for fiscal 2012. Analysts expect the company to earn $6.36 per share, on revenues of $42.94 billion.

Register
To receive FREE breaking news email alerts for FedEx Corporation and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.